NCT03535077View on ClinicalTrials.gov

Assessing Tissue Remodeling in the Skin Using SFI (Skin Fluorescence Imaging)

CompletedOBSERVATIONAL
Enrollment

186

Participants

Timeline

Start Date

January 24, 2018

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Skin LesionMelanoma (Skin)Mole
Interventions
OTHER

Diagnostic Test

Imaging of the suspicious lesion after application of ORL-1 dye prior to biopsy

Trial Locations (6)

84112

University of Utah, Salt Lake City

91324

Quest Dermatology Research, Northridge

92697

UCI Center for Clinical Research, Irvine

94025

Divya Railan, Md, Faad, Menlo Park

94538

Center for Dermatology Clinical Research, Inc, Fremont

94590

Solano Dermatology Associates, Vallejo

Sponsors

Lead Sponsor

Orlucent, Inc
All Listed Sponsors
lead

Orlucent, Inc

INDUSTRY

NCT03535077 - Assessing Tissue Remodeling in the Skin Using SFI (Skin Fluorescence Imaging) | Biotech Hunter | Biotech Hunter